"The Council of the European Union has formally adopted the Falsified Medicines Directive ... which had been approved by the European Parliament in February 2011. The Directive brings in numerous new initiatives to help safeguard the medicines supply chain and protect patients in order to prevent the circulation of falsified medicines. While its aims are generally welcomed, the Directive will impact businesses at all levels of the supply chain and its measures are expected to be expensive to implement.
Scope of the Directive
A falsified medicinal product is defined by the Directive as:
“any medicinal product with a false representation of: (a) its identity, including its packaging and labelling, its name or its composition as regards any of the ingredients including excipients and the strength of those ingredients; (b) its source, including its manufacture, its country of manufacturing, its country of origin or its marketing authorisation holder; or (c) its history, including the records and documents relating to the distribution channels used” [this would appear to cover products bearing infringing trade marks, but ...].The Directive does not deal with unintentional quality defects or the protection of intellectual and industrial property such as registered trade marks or patent rights. The focus and purpose of the Directive is to protect against the major health threat that can arise from falsified medicines.
The measures introduced by the Directive will apply generally to all prescription products unless they are specifically exempted, but not to non-prescription medicines unless they are considered to be at high risk of falsification. ..."
this message is for you. The fourth guested piece by Keith Mallinson (WiseHarbor) for IP Finance, here, deals with "Fixing IP Prices with Royalty Rate Caps and Patent Pools". The PatLit patent litigation weblog cautions readers about the dangers of compromising the role of expert witnesses by teaching them to be partisan (even though they are ...). Art & Artifice explains how the US Supreme Court reaches the conclusion that computer games are works of art. There's also a crackingly good debut post by Naomi Jane Gray (1709 Blog) here on 'red-flag' knowledge and wilful blindness under the US's Digital Millennium Copyright Act.
|... but is this mouse patented?|